ERBB2 and neoplasm: To evaluate the cytotoxicity, HER2+ tumor cell lines (SK-BR-3, BT-474, SK-OV-3, and NCI-N87), and HER2– tumor cell lines (MCF-7 and MDA-MB-468) were treated with three generated maleamic methyl ester-based ADCs.